Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype, characterized by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression, as well as lack of gene amplification and/or protein overexpression of the human epidermal growth factor receptor 2 (HER2) [1]. Here, ESR1 is linked to breast carcinoma.